Apnex Medical has received CE Mark approval for its Hypoglossal Nerve Stimulation (HGNS) system for the treatment of obstructive sleep apnea (OSA). The pacemaker-like device monitors the patient’s breathing patterns and is activated during sleep to stimulate the hypoglossal nerve, timed to the patient’s own respiration. The hypoglossal nerve in turn controls muscles in the upper airway, ensuring they keep the airway open. The system is programmed to work only when the patient is asleep, but can also be turned on and off through a handheld controller. A clinical study is currently underway to test the effectiveness of the system in patients with OSA who were not helped with CPAP and other OSA treatments.
Press release: Apnex Medical, Inc. Receives CE Mark Approval for HGNS® System to Treat Obstructive Sleep Apnea…
Product page: Apnex HGNS Therapy…
Flashback: Apnex Hypoglossal Nerve Stimulation for OSA